A Nicotinamide Phosphoribosyltransferase Inhibitor, FK866, Suppresses the Growth of Anaplastic Meningiomas and Inhibits Immune Checkpoint Expression by Regulating STAT1

Anaplastic meningioma is classified as a World Health Organization (WHO) grade III tumor and shows a strong tendency to recur. Although the incidence of anaplastic meningioma is low, the high rate of recurrence and death still makes treatment a challenge. A proteomics analysis was performed to inves...

詳細記述

書誌詳細

主要な著者:	Yuxuan Deng, Boyi Hu, Yazhou Miao, Jing Wang, Shaodong Zhang, Hong Wan, Zhen Wu, Yifan Lv, Jie Feng, Nan Ji, Deric Park, Shuyu Hao
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2022-04-01
シリーズ:	Frontiers in Oncology
主題:	anaplastic meningioma NAMPT NAMPT inhibitor immune checkpoint cell cycle proteomics
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fonc.2022.836257/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!